CHU Dijon Bourgogne - Hopital Francois Mitterrand

Dijon 21079

0 studies enrolling now · 4 studies all time

What they study most

Atherosclerosis, Cardiovascular Diseases, Clostridium Difficile Infection, Hypertriglyceridemia, Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention, Sjogrens Syndrome

Studies at this site

• Nipocalimab in Moderate to Severe Sjogren's Disease — Running, not enrolling
• A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years — Completed
• A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia — Completed
• Clostridium Difficile Vaccine Efficacy Trial — Completed